Aspire Biopharma Holdings, Inc. Balance Sheet
ASBP|1 years of annual SEC 10-K data (FY2025-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity. All figures from audited SEC 10-K filings.
Aspire Biopharma Holdings, Inc. had $147,989 in total assets with negative shareholders' equity of $487,861 as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -33.16 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 |
|---|---|
| Inventory | $253.2K |
| Current Assets | $148.0K |
| Total Assets | $148.0K |
| Current Liabilities | $1.7M |
| Shareholders' Equity | -$487.9K |